Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

BMP Pathway Alterations in Chronic Myelogenous Leukemia Lead to the Amplification of Primitive Progenitors Output in Chronic Phase

Franck E. Nicolini, MD, PhD, Bastien Laperoussaz, PhD student, Sandrine Jeanpierre, Tech., Karen Sagorny, PhD, Bastien Kaniewski, Tech., Stephane Morisset, Stat., Stéphanie Salesse, PhD, Thibault Voeltzel, PhD, Véronique maguer-Satta, PhD

Blood (2012) 120 (21): 1663.

https://doi.org/10.1182/blood.V120.21.1663.1663

Published: 2012

Journal Articles

Twist-1 Expression Represents a Novel Prognostic Factor in Chronic Myelogenous Leukemia.

Franck Emmanuel Nicolini, MD, PhD, Erika Cosset, MSc, Ghassan Hamdan, MSc, Sandrine Jeanpierre, BSc, Charles Dumontet, MD, PhD, Thibault Voeltzel, PhD, Alain Puisieux, PharmD, PhD, Véronique Maguer-Satta, PhD

Blood (2009) 114 (22): 2592.

https://doi.org/10.1182/blood.V114.22.2592.2592

Published: 2009

Journal Articles

The Bone Morphogenetic Protein (BMP)-4 Is Involved in the Regulation of Human Megakaryocytic Differentiation during Thrombopoietin Signaling.

Franck E Nicolini, MD, PhD, Sandrine Jeanpierre, BSc, Bastien Kaniewski, BSc, Charles Dumontet, MD, PhD, Ruth Rimokh, PhD, Alain Puisieux, Pharmd, PhD, Véronique Maguer-Satta, PhD

Blood (2008) 112 (11): 1339.

https://doi.org/10.1182/blood.V112.11.1339.1339

Published: 2008

Journal Articles

In Vitro Toxicity of Fludarabine on Normal Bone Marrow (BM) Progenitors Suggests Its Involvement in the Impairment of Hematopoietic Progenitor (HP) Mobilization.

Céline Richard, PhD, Véronique Maguer-Satta, PhD, Juliette Berger, Sandrine Jeanpierre, Franck E. Nicolini, MD, PhD, Olivier Tournilhac, MD, PhD, Mauricette Michallet, MD, PhD, Marc G. Berger, MD, PhD

Blood (2007) 110 (11): 1192.

https://doi.org/10.1182/blood.V110.11.1192.1192

Published: 2007

Journal Articles

Recurrent involvement of the MLL gene in adult T-lineage acute lymphoblastic leukemia

Sandrine Hayette, Isabelle Tigaud, Véronique Maguer-Satta, Laurent Bartholin, Xavier Thomas, Christiane Charrin, Mylène Gadoux, Jean-Pierre Magaud, Ruth Rimokh

Blood (2002) 99 (12): 4647–4649.

https://doi.org/10.1182/blood-2002-03-0717

Published: 2002

NARROW

BMP Pathway Alterations in Chronic Myelogenous Leukemia Lead to the Amplification of Primitive Progenitors Output in Chronic Phase

Twist-1 Expression Represents a Novel Prognostic Factor in Chronic Myelogenous Leukemia.

The Bone Morphogenetic Protein (BMP)-4 Is Involved in the Regulation of Human Megakaryocytic Differentiation during Thrombopoietin Signaling.

In Vitro Toxicity of Fludarabine on Normal Bone Marrow (BM) Progenitors Suggests Its Involvement in the Impairment of Hematopoietic Progenitor (HP) Mobilization.

Recurrent involvement of the MLL gene in adult T-lineage acute lymphoblastic leukemia

Email alerts

ASH Publications

American Society of Hematology

BMP Pathway Alterations in Chronic Myelogenous Leukemia Lead to the Amplification of Primitive Progenitors Output in Chronic Phase

Twist-1 Expression Represents a Novel Prognostic Factor in Chronic Myelogenous Leukemia.

The Bone Morphogenetic Protein (BMP)-4 Is Involved in the Regulation of Human Megakaryocytic Differentiation during Thrombopoietin Signaling.

In Vitro Toxicity of Fludarabine on Normal Bone Marrow (BM) Progenitors Suggests Its Involvement in the Impairment of Hematopoietic Progenitor (HP) Mobilization.

Recurrent involvement of the MLL gene in adult T-lineage acute lymphoblastic leukemia

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only